These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

583 related items for PubMed ID: 18468387

  • 1. Solid-state characterization and dissolution properties of bicalutamide-beta-cyclodextrin inclusion complex.
    Patil AL, Pore YV, Kuchekar BS, Late SG.
    Pharmazie; 2008 Apr; 63(4):282-5. PubMed ID: 18468387
    [Abstract] [Full Text] [Related]

  • 2. Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.
    Aleem O, Kuchekar B, Pore Y, Late S.
    J Pharm Biomed Anal; 2008 Jul 15; 47(3):535-40. PubMed ID: 18367363
    [Abstract] [Full Text] [Related]

  • 3. Preparation, characterization and dissolution enhancement of mefloquine hydrochloride-betaCD inclusion complex.
    Patil SS, Patil AL.
    Pharmazie; 2011 Jun 15; 66(6):416-20. PubMed ID: 21699079
    [Abstract] [Full Text] [Related]

  • 4. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW, Kim MS, Kim JS, Park HJ, Lee S, Woo JS, Hwang SJ.
    Eur J Pharm Biopharm; 2007 Jun 15; 66(3):413-21. PubMed ID: 17240129
    [Abstract] [Full Text] [Related]

  • 5. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
    Liu L, Zhu S.
    J Pharm Biomed Anal; 2006 Jan 23; 40(1):122-7. PubMed ID: 16095859
    [Abstract] [Full Text] [Related]

  • 6. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM, Elkheshen SA, Ghorab MM.
    Eur J Pharm Biopharm; 2008 Nov 23; 70(3):819-27. PubMed ID: 18655829
    [Abstract] [Full Text] [Related]

  • 7. Formation of bicalutamide nanodispersion for dissolution rate enhancement.
    Li C, Li C, Le Y, Chen JF.
    Int J Pharm; 2011 Feb 14; 404(1-2):257-63. PubMed ID: 21093558
    [Abstract] [Full Text] [Related]

  • 8. Development and characterization of bicalutamide-poloxamer F68 solid dispersion systems.
    Sancheti PP, Vyas VM, Shah M, Karekar P, Pore YV.
    Pharmazie; 2008 Aug 14; 63(8):571-5. PubMed ID: 18771004
    [Abstract] [Full Text] [Related]

  • 9. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.
    Onyeji CO, Omoruyi SI, Oladimeji FA.
    Pharmazie; 2007 Nov 14; 62(11):858-63. PubMed ID: 18065103
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
    Figueiras A, Carvalho RA, Ribeiro L, Torres-Labandeira JJ, Veiga FJ.
    Eur J Pharm Biopharm; 2007 Sep 14; 67(2):531-9. PubMed ID: 17451924
    [Abstract] [Full Text] [Related]

  • 12. Solubility enhancement of celecoxib using beta-cyclodextrin inclusion complexes.
    Rawat S, Jain SK.
    Eur J Pharm Biopharm; 2004 Mar 14; 57(2):263-7. PubMed ID: 15018983
    [Abstract] [Full Text] [Related]

  • 13. Nanosized bicalutamide and its molecular structure in solvents.
    Le Y, Ji H, Chen JF, Shen Z, Yun J, Pu M.
    Int J Pharm; 2009 Mar 31; 370(1-2):175-80. PubMed ID: 19101616
    [Abstract] [Full Text] [Related]

  • 14. Analysis of triclosan inclusion complexes with β-cyclodextrin and its water-soluble polymeric derivative.
    Jug M, Kosalec I, Maestrelli F, Mura P.
    J Pharm Biomed Anal; 2011 Apr 05; 54(5):1030-9. PubMed ID: 21215544
    [Abstract] [Full Text] [Related]

  • 15. Physicochemical characteristics and bioavailability of a novel intestinal metabolite of ginseng saponin (IH901) complexed with beta-cyclodextrin.
    Lee PS, Han JY, Song TW, Sung JH, Kwon OS, Song S, Chung YB.
    Int J Pharm; 2006 Jun 19; 316(1-2):29-36. PubMed ID: 16574357
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inclusion complexes of noscapine in beta-cyclodextrin offer better solubility and improved pharmacokinetics.
    Madan J, Dhiman N, Parmar VK, Sardana S, Bharatam PV, Aneja R, Chandra R, Katyal A.
    Cancer Chemother Pharmacol; 2010 Feb 19; 65(3):537-48. PubMed ID: 19597818
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.